XML 70 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Earnings Per Share [Abstract]    
Net loss attributable to Adaptive Biotechnologies Corporation $ (62,736) $ (40,642)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted 141,697,252 138,967,754
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted $ (0.44) $ (0.29)